GO
Loading...

Enter multiple symbols separated by commas

Health Care Equipment and Supplies

More

  • In a letter released on Wednesday, the organization urged Health and Human Services Secretary Sylvia Burwell to withdraw the proposal, saying pharmaceutical companies could "sell more drugs by making them seem safer than FDA has judged them to be." The FDA said it would allow distribution of new information in medical journals showing that the severity or...

  • Got diabetes? There's an app for that Monday, 9 Mar 2015 | 6:34 PM ET

    CHICAGO, March 9- U.S. health researchers said on Monday they are targeting millions of smartphone users with Apple Inc's new software tool, hoping to collect an unprecedented amount of data on major diseases by tracking their behaviors via iPhone. Scientists from Stanford University School of Medicine and Weill Cornell Medical College are among the first to...

  • CHICAGO, March 9- Apple Inc on Monday released ResearchKit, an open-source software tool designed to give scientists a new way to gather information on patients by using their iPhones. They include Stanford University School of Medicine and Weill Cornell Medical College. "With hundreds of millions of iPhones in use around the world, we saw an opportunity for...

  • SEATTLE, March 5- A Washington state woman has filed a lawsuit against a hospital and a leading medical-device manufacturer claiming her husband died from a drug-resistant "superbug" he contracted from a contaminated medical scope, her lawyer said on Thursday. Theresa Bigler, of Woodway, is seeking unspecified monetary damages for the death of her husband...

  • The scopes were linked to the exposure of 179 patients to drug-resistant bacteria at UCLA's Ronald Reagan Medical Center in Los Angeles and may have contributed to two deaths. In early 2014, following a superbug outbreak at a hospital in Illinois, the FDA asked Fujifilm Holdings Corp, Olympus Corp and Pentax, which make the devices, to submit their test results...

  • *Cyberonics will have 54 pct of new group; Sorin 46 pct. MILAN, Feb 26- Italian medical device maker Sorin and its smaller U.S. peer Cyberonics Inc announced a merger on Thursday to create a global leader in cardiac surgery and neuromodulation with an equity value of $2.7 billion. Sorin's boss Andre-Michel Ballester will become chief executive and the board will be...

  • MILAN, Feb 26- United States- based medical device maker Cyberonics Inc has agreed to buy Sorin SpA in an all-stock deal that the Italian company said values it at about $1.4 billion. Cyberonics will hold a 54 percent stake in the new company and Sorin the rest. Cyberonics shareholders will receive one share of the new company for every share held, while Sorin...

  • Feb 17- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson& Johnson to settle a long-running lawsuit over Boston Scientific's 2005 acquisition of rival Guidant. J&J had sought more than $7 billion in damages after it lost a bidding war to Boston Scientific following an initial deal to buy Guidant for $21.5...

  • Feb 17- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson& Johnson to settle a long-running breach of merger lawsuit over Boston Scientific's 2005 acquisition of rival Guidant. J&J, which agreed to permanently dismiss its action without acknowledgment of liability by Guidant, had sought more than $7...

  • Feb 17- Medical device maker Medtronic Plc reported a better-than-expected quarterly profit, helped mainly by increased sales in its cardiac and vascular business, its largest. With sales of $2.22 billion in the third quarter ended Jan. 23, the business accounted for a little over half of overall sales. The company, which completed its acquisition of Ireland-...

  • Medtronic profit rises on higher cardiac device sales Tuesday, 17 Feb 2015 | 7:36 AM ET

    Feb 17- Medical device maker Medtronic Plc reported a 28 percent rise quarterly profit, helped mainly by increased sales in its cardiac and vascular business, its largest. The company, which completed its acquisition of Ireland- based Covidien Plc in January, said its net profit rose to $977 million, or 98 cents per share, for the third quarter ended Jan. 23, from $762...

  • NEW YORK/ BOSTON, Feb 11- Security experts are warning healthcare and insurance companies that 2015 will be the "Year of the Healthcare Hack," as cybercriminals are increasingly attracted to troves of personal information held by U.S. insurers and hospitals that command high prices on the underground market. "People feel that this will be the year of medical...

  • U.S. challenges China export subsidy program Wednesday, 11 Feb 2015 | 9:08 AM ET

    WASHINGTON, Feb 11- The United States on Wednesday challenged a Chinese export subsidy program for products including textiles, medical products and agriculture, alleging the support was illegal under international trade law. There are already 24 disputes before the WTO involving the United States and China, 15 of them brought by the United States.

  • UPDATE 2-Boston Scientific profit beats Street by a cent Wednesday, 4 Feb 2015 | 12:00 PM ET

    *4th- qtr adj/shr $0.22 vs est $0.21. Feb 4- Boston Scientific Corp's adjusted quarterly profit edged past the average analyst estimate and the medical device maker reported a growth in sales for the fifth straight quarter, helped by continued demand for its heart devices. Boston Scientific's sales growth and improving margin have been encouraging in the...

  • Feb 4- Medical device maker Boston Scientific Corp posted a 19 percent fall in fourth-quarter profit as litigation charges more than doubled. Boston Scientific, along with Johnson& Johnson, awaits a New York federal court decision in what could culminate into the final leg of a more than eight-year battle between the two. J&J is seeking more than $7.2 billion in...

  • Boston Scientific profit falls as litigation costs soar Wednesday, 4 Feb 2015 | 7:16 AM ET

    Feb 4- Medical device maker Boston Scientific Corp posted a 19 percent fall in fourth-quarter profit as litigation charges more than doubled. The company's net income fell to $87 million, or 6 cents per share, in the quarter ended Dec. 31 from $108 million, or 8 cents per share, a year earlier. Excluding charges for restructuring, litigation and other costs, the...

  • *Sanofi struggling to find new CEO in narrow field. PARIS, Jan 30- Barring a last-minute breakthrough, drugs firm Sanofi's Chairman Serge Weinberg may have to acknowledge in his results presentation next week that the hunt for a new chief executive is not going well. Paris- schooled Olivier Bohuon, chief executive of British medical devices maker Smith& Nephew,...

  • 2015's strong outlook for healthcare IPOs   Thursday, 29 Jan 2015 | 5:40 AM ET
    2015's strong outlook for healthcare IPOs

    Cathrin Petty, co-head of EMEA healthcare at JP Morgan, says the U.K. has the capacity to be a successful market for life sciences, and the year ahead for healthcare IPOs looks strong.

  • The rise and rise of life sciences   Thursday, 29 Jan 2015 | 4:55 AM ET
    The rise and rise of life sciences

    George Freeman MP, minister of life sciences in the U.K., says there's been a "resurgence" for life sciences and healthcare investment.

  • NEW YORK, Jan 29- When Marty Weinstein decided to quit smoking, he took a friend's advice and tried electronic cigarettes rather than government-approved nicotine replacement products. E-cigarette makers in the United States are barred from explicitly marketing the products as smoking cessation devices, but have found ways to appeal legally to smokers who...